Blockade of CD95/CD95L Death Signaling Enhances CAR-T Cell Persistence and Antitumor Efficacy
We compared the transcriptomic profiles of CAR-T cells after antigen stimulation with or without APG101 treatment. CAR-T cells were co-cultured with target cells for 12 hours in the presence or absence of APG101, and subsequently sorted for RNA sequencing.